Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
Carlsquare Equity Research initiates coverage of Pharmiva with a positive view on the launch of the infection treatment Vernivia. We see good prospects of expected news flow and gradual roll-out to more geographic markets supporting the shares.